Chaiyarat P, Manachevakul S, Phopongsin S. Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comparison of Erlotinib and Osimertinib within the Thai Healthcare System. J.HPLA [internet]. 2026 Apr. 30 [cited 2026 Sep. 29];12(2):383-94. available from: https://so05.tci-thaijo.org/index.php/journal_law/article/view/286578